Biomere Tech

11:30 AM - 11:45 AM (JST), Wednesday, March 6, 2019 ・ 2nd Floor
Biomere Tech will advance the treatment of osteoarthritis (OA) with its innovative therapy- silk protein based knee patch with microsurgery insertion. OA currently impacts 27 million US adults. The disease occurs when cartilage breaks down in the joint space causing pain, inflammation and immobility. Biomere Tech’s technology is silk- a novel biomaterial known for its strength, lubrication, and drug-delivery capabilities which can be applied directly into the joint to provide long lasting pain relief and increased local bone density, and further prevent the progression of disease.
Silk technology is an extension work of previous DARPA project when Tim was the leader of a DARPA projects back in 2005. Tim is the pioneer with years of experience and various patents in silk technology. Founded by Tim Lo and his team, has diverse expertise necessary to commercialize this product.
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
Not Provided
Development Phase of Primary Product:
Not Provided
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Founder
Biomere Tech